MedTrace Logo

Occupational and Environmental Origins of ANCA Vasculitis: Contribution of Data From the National Network for Vigilance and Prevention of Occupational Pathologies (RNV3P)

NCT05416723 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 302

Last updated 2022-06-13

No results posted yet for this study

Summary

The main objective is to identify specific risk factors for ANCA vasculitis of occupational and/or environmental origin (exposures identified by questioning, geographical distribution of cases) from the RNV3P data.

The secondary objectives are as follows:

* Description of cases of ANCA vasculitis seen in French occupational pathology consultation centres:

* reasons for consultation,
* occupational and environmental etiologies described
* occupational situations responsible
* aptitude notices
* recognition as an occupational disease
* Identification of specific risk factors for ANCA vasculitis of occupational and/or environmental origin (exposures identified on questioning, geographical distribution of cases).
* For occupational and non-occupational cases of ANCA vasculitis: identification of difficulties encountered by patients at work and proposed work adaptations.
* Estimation of the number of applications for recognition of disabled worker status made within this patient group.
* Identification of clinical severity and autoimmune profiles of ANCA vasculitis of occupational and/or environmental origin.

Conditions

  • ANCA Associated Vasculitis
  • Occupational Diseases
  • Environmental Exposure

Sponsors & Collaborators

  • University Hospital, Brest

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-01
Primary Completion
2022-07-01
Completion
2022-08-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05416723 on ClinicalTrials.gov